Physical Activity and Pregnancy: Practices and Knowledge of Pregnant Women

February 10, 2026 updated by: Université de Reims Champagne-Ardenne

Physical activity (PA) is defined as 'any bodily movement produced by skeletal muscles that requires the expenditure of energy (...) physical activity of moderate or sustained intensity has beneficial effects on health'. This activity is characterised by its duration, intensity, frequency and the way in which it is practised.

Physical activity is a behaviour that has a protective effect on various chronic diseases and is associated with a number of important vital parameters, such as heart rate, respiratory rate, blood pressure, body mass index (BMI) and blood sugar levels, all of which are essential measures that provide an overview of an individual's overall state of health.

Pregnancy is a period during which many physiological and hormonal changes take place. Pregnancy is a period during which physical activity is reduced and there is a tendency towards a sedentary lifestyle. However, physical activity has a number of benefits for pregnant women, including the prevention of a number of pregnancy-related pathologies that can be harmful to both the woman and her baby, such as gestational diabetes, pre-eclampsia and pregnancy-induced hypertension, which can lead to premature birth, increased risk of macrosomia and hypotrophy. What's more, physical activity helps pregnant women to control weight gain, reduce back pain and alleviate anxiety and depression.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The main objective is to describe the physical activity of pregnant women.

The secondary objectives are:

  • To investigate the factors associated with a sedentary lifestyle among pregnant women, in particular the lack of knowledge among pregnant women about physical activity during pregnancy
  • To describe the information received by pregnant women about physical activity during pregnancy

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
    • Champagne-Ardenne
      • Reims, Champagne-Ardenne, France, 51100
        • Gestonnairedu CURRS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Pregnant women

Description

Inclusion Criteria:

  • Pregnant in any trimester,
  • Nulliparous or multiparous,
  • Adults,
  • Accepting to take part in the study.

Exclusion Criteria:

  • Minors
  • Protected by law (guardianship, curatorship, safeguard of justice)
  • Refusing to take part in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ricci Gagnon test
Time Frame: Day 0

The physical activity of pregnant women will be assessed using the Ricci Gagnon test. The test consists of 9 questions coded from 1 to 5, giving a score out of 45 points.

The score is interpreted as follows: under 18: inactive; between 18 and 35: active; over 35: very active.
Day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Université de Reims Champagne-Ardenne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 26, 2025

Primary Completion (Actual)

March 24, 2025

Study Completion (Actual)

April 1, 2025

Study Registration Dates

First Submitted

February 10, 2026

First Submitted That Met QC Criteria

February 10, 2026

First Posted (Actual)

February 18, 2026

Study Record Updates

Last Update Posted (Actual)

February 18, 2026

Last Update Submitted That Met QC Criteria

February 10, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2024_RIPH_18_grossesse-acti

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy

Clinical Trials on data collection

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe